SML1295

RBC8

≥98% (HPLC)

• Synonim(y): 6-Amino-4-(2,5-dimethoxyphenyl)-1,4-dihydro-3-(2-naphthalenyl)-pyrano[2,3-c]pyrazole-5-carbonitrile
• Wzór empiryczny (zapis Hilla): C₂₅H₂₀N₄O₃
• Numer CAS: 361185-42-4
• Masa cząsteczkowa: 424.45
• NACRES: NA.77
• PubChem Substance ID: 329825769
• UNSPSC Code: 12352200
• MDL number: MFCD03341241
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 20 mg/mL, clear
• storage temp.: −20°C
• SMILES string: NC1=C(C#N)C(C2=C(OC)C=CC(OC)=C2)C(C(C3=CC=C(C=CC=C4)C4=C3)=NN5)=C5O1
• InChI: 1S/C25H20N4O3/c1-30-17-9-10-20(31-2)18(12-17)21-19(13-26)24(27)32-25-22(21)23(28-29-25)16-8-7-14-5-3-4-6-15(14)11-16/h3-12,21H,27H2,1-2H3,(H,28,29)
• InChI key: CLMQBVUFKIKYLU-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

RBC8 is a selective inhibitor of the Ras-like GTPases RalA and RalB, downstream mediators of Ras signalling, without direct inihibition of Ras or RhoA activity. RBC8 binds to a site on the GDP-bound form of Ral, its inactive state, inhibiting the binding of Ral to its effectors, such as Ral-binding protein 1 (RALBP1; also known as RLIP760, which are involved in proliferation, survival, and metastasis of several human cancers. RBC8 inhibited growth in human luung cancer cell lines with IC₅₀ values of 2.0 μM in H2122 cells and 1.3 μM in H358 cells, and also inihbited tumor xenograft growth..

RBC8 is a selective inhibitor of the Ras-like GTPases RalA and RalB.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable